Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsINTRAVENOUSStandard

SODIUM THIOSULFATE

SODIUM THIOSULFATE

Standard Dose
12.5GM/50ML (250MG/ML)
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary

Approval overview SODIUM THIOSULFATE is listed in Drugs@FDA under application 203923 (NDA).

Review priority: STANDARD Marketing status: Prescription Active ingredient SODIUM THIOSULFATE Form and strength SOLUTION;INTRAVENOUS - 12.5GM/50ML (250MG/ML) Sponsor HOPE PHARMS Submission history Latest submission status date: 2020-06-19 00:00:00.

Structured Monograph

Clinical summary

Approval overview SODIUM THIOSULFATE is listed in Drugs@FDA under application 203923 (NDA). Review priority: STANDARD Marketing status: Prescription Active ingredient SODIUM THIOSULFATE Form and strength SOLUTION;INTRAVENOUS - 12.5GM/50ML (250MG/ML) Sponsor HOPE PHARMS Submission history Latest submission status date: 2020-06-19 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Prescription
  • • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.